COMMUNIQUÉ DE PRESSE
News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Revenues of EUR 15.5 million (fully consolidated) +45% Q2 2025 revenues growth compared to Q1 2025 Developments further materializing in 2025
FDE reports €15.5M revenues for H1 2025, a 45% Q2 growth compared to Q1. Development plans include green electricity units and RNG production in Norway, targeting strong growth -
COMMUNIQUÉ DE PRESSE
Onco-Innovations Enters into LOI with Inka Health to Implement AI Technology Toward Cancer Detection and Drug Development
Onco-Innovations Limited announces letter of intent with Inka Health Corp. to acquire AI platform for precision oncology. Potential acquisition set to revolutionize drug development processes -
COMMUNIQUÉ DE PRESSE
Chiffre d'affaires au S1 2025 de 15,5 M EUR (en intégration globale) Progression des revenus du T2 2025 par rapport au T1 2025 (+45%) Matérialisation des développements en 2025
La Française de l'Énergie affiche un chiffre d'affaires semestriel de 15,5 M€, en progression au T2 2025. Développements solides en énergie verte et gaz, objectifs ambitieux pour 2030 -
-
COMMUNIQUÉ DE PRESSE
Results of LEGEND evaluating lanifibranor in combination with empagliflozin in MASH selected for oral presentation at the upcoming EASL SLD Summit 2025
Inventiva announces selection of LEGEND trial results evaluating lanifibranor and empagliflozin for oral presentation at EASL SLD Summit 2025, showing positive outcomes in MASH patients with T2D
